Pain medicine

Pupillary dilation to monitor nociception in awake volunteers: A stimuli-randomised placebo-controlled study

Eur J AnaesthesiolPublished Randomised controlled trial

Authors' conclusion

In awake volunteers, PRD differentiates between painful and nonpainful stimuli and correlates with pain intensity.

Study context

Population
Healthy awake volunteers (25 ± 2 years, 50% male), Germany
Participants
30 volunteers
Comparison
Pupillary reflex dilation to painful vs nonpainful stimuli
Primary endpoint
Pupil dilatation as PRD (%) measured with AlgiScan during rest and during/after each stimulus
Follow-up
60 s
Methodological detailsplacebo-controlled, stimuli-randomised, single-centre, BG University Hospital Bergmannsheil Bochum, Germany, November 2021–January 2022
  • Placebo-controlled
  • Stimuli-randomised
  • Single-centre
  • BG University Hospital Bergmannsheil Bochum, Germany, November 2021–January 2022

Primary result

As reported in the abstract

PRD (%)

Announced painful stimulus (APS) vs nonpainful stimulus (NPS): P = 0.024 · UPS vs Rest: P < 0.001 · UPS vs Placebo: P < 0.001 · UPS vs NPS: P < 0.0001

Further findings

OutcomeAPSUPSPlaceboNPSP value
Subjective pain intensity (NRS 0–10)APS vs UPS6.0 ± 1.95.5 ± 1.70.0 ± 0.00.0 ± 0.0P = 0.007
Subjective pain intensity (NRS 0–10)APS vs PlaceboP = 0.027
Subjective pain intensity (NRS 0–10)APS vs NPSP = 0.001

Correlation of pupillary reflex dilation (PRD) with pain intensity

Spearman r
0.35
  • P < 0.0001

Original publication

Pupillary dilation to monitor nociception in awake volunteers: A stimuli-randomised placebo-controlled study. Eur J Anaesthesiol. Published 24 February 2025. doi:10.1097/eja.0000000000002143

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.